[
  {
    "ts": "2025-12-19T13:59:00+00:00",
    "headline": "Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema",
    "summary": "NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a4acac6a-21ec-3f28-a403-b9b9ec0480d2",
      "content": {
        "id": "a4acac6a-21ec-3f28-a403-b9b9ec0480d2",
        "contentType": "STORY",
        "title": "Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema",
        "description": "",
        "summary": "NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.",
        "pubDate": "2025-12-19T13:59:00Z",
        "displayTime": "2025-12-19T13:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpV4giEb4QjgN71LPYFzIw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QcLiFahMpkHBfBp4mOYpEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T13:09:17+00:00",
    "headline": "Dow Jones Futures: Tech Stocks Eye Key Level; Oracle, Nike, FedEx In Focus",
    "summary": "Futures signal the stock market may test key resistance again after Thursday's Micron-inflation gains. Oracle, FedEx, Nike are early movers.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-micron-cool-inflation-nike-fed-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "f226d2f7-9938-3b8e-b27f-83c71154c6f0",
      "content": {
        "id": "f226d2f7-9938-3b8e-b27f-83c71154c6f0",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Tech Stocks Eye Key Level; Oracle, Nike, FedEx In Focus",
        "description": "",
        "summary": "Futures signal the stock market may test key resistance again after Thursday's Micron-inflation gains. Oracle, FedEx, Nike are early movers.",
        "pubDate": "2025-12-19T13:09:17Z",
        "displayTime": "2025-12-19T13:09:17Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f226d2f7-9938-3b8e-b27f-83c71154c6f0/dow-jones-futures-tech.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oVfVEeaR27sq2IXfqgIXsA--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K0OQOn8hh6tqhnD.fMcIdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-micron-cool-inflation-nike-fed-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "FDX"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "RDDT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "GMED"
            },
            {
              "symbol": "GTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T11:40:40+00:00",
    "headline": "Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs",
    "summary": "Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.",
    "url": "https://www.clinicaltrialsarena.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "55661144-769f-3ff6-a59a-dfbc91235763",
      "content": {
        "id": "55661144-769f-3ff6-a59a-dfbc91235763",
        "contentType": "STORY",
        "title": "Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs",
        "description": "",
        "summary": "Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.",
        "pubDate": "2025-12-19T11:40:40Z",
        "displayTime": "2025-12-19T11:40:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Eli Lilly's oral GLP-1RA",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5fEIHA4QhzfNW_NgJg12g--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tU7tHL87faS1htB7I4vb8w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-oral-glp-1ra-114040778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T06:30:00+00:00",
    "headline": "Elanco CEO Bites Off More Shares of Fast-Rising Stock",
    "summary": "Elanco Animal Health  stock is having a great year—and Chief Executive Jeffrey Simmons is champing at the bit.  Simmons spent $478,500 to buy 22,000 shares of the stock on Dec. 11 for an average price of $21.75, according to a Form 4 filed with the Securities and Exchange Commission.  The purchase was made by a revocable trust and brings his total indirect ownership to 167,000 shares.",
    "url": "https://www.barrons.com/articles/elanco-ceo-stock-price-buy-2cd8bfdc?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7a4c1c98-6ec6-3e69-ace7-9b21632b710b",
      "content": {
        "id": "7a4c1c98-6ec6-3e69-ace7-9b21632b710b",
        "contentType": "STORY",
        "title": "Elanco CEO Bites Off More Shares of Fast-Rising Stock",
        "description": "",
        "summary": "Elanco Animal Health  stock is having a great year—and Chief Executive Jeffrey Simmons is champing at the bit.  Simmons spent $478,500 to buy 22,000 shares of the stock on Dec. 11 for an average price of $21.75, according to a Form 4 filed with the Securities and Exchange Commission.  The purchase was made by a revocable trust and brings his total indirect ownership to 167,000 shares.",
        "pubDate": "2025-12-19T06:30:00Z",
        "displayTime": "2025-12-19T06:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7a4c1c98-6ec6-3e69-ace7-9b21632b710b/elanco-ceo-bites-off-more.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ul8c3lkzPZ1nRklfTFfvHQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w7Brg8mhI_kGJzQH8j4LDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/elanco-ceo-stock-price-buy-2cd8bfdc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELAN"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]